Indicus Pharma’s Generic Propafenone Hydrochloride Receives Approval in the US
Indicus Pharma`s Generic Nateglinide Receives Approval In US
Indicus`s Generic Desipramine HCl approved in US as antidepressant drug
On April 12, 2016, Indicus Pharma (Indicus or Company), which was incorporated as part of a strategic alliance with India’s USV Private Limited (USV), received final approval of its abbreviated new drug application (ANDA#203419) for an AB-rated generic version of Eisai Co. Ltd’s Aricept® (donepezil hydrochloride) Tablets, 23mg. With this approval, Indicus has obtained approval for all three strengths of Aricept (5mg, 10mg and 23mg). USV already manufactures the 5mg and 10mg strengths for Indicus in India. Assuming that USV manufactures the 23mg strength in India for Indicus, the opportunity for U.S. government sales via the Federal Supply Schedule (FSS) remains open.
Indicus Pharma`s Generic Donepezil HCl approved in US to treat dementia